Dupilumab and the potential risk of eosinophilic pneumonia: case report, literature review, and FAERS database analysis: Eosinophilic pneumonia (EP) is a rare but noteworthy adverse effect linked to dupilumab, an interleukin-4… … #immunology https://t.co/G
17,568 followers
11,351 followers
Interesante. Dupilumab (anticuerpo anti-subunidad alfa del receptor del interleucina 4) y el riesgo potencial de neumonía eosinofílica: un caso, revisión de la literatura y análisis de la base de datos FAERS. https://t.co/D8XJYnVh7H
32,972 followers
New Research: Dupilumab and the potential risk of eosinophilic pneumonia: case report, literature review, and FAERS database analysis: Eosinophilic pneumonia (EP) is a rare but noteworthy adverse effect linked to dupilumab, an interleukin-4… https://t.co/t